Obianuju C Okeke, MD | |
15200 S.w Freeway, 210, Sugar Land, TX 77478 | |
(281) 313-7000 | |
(281) 313-7001 |
Full Name | Obianuju C Okeke |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 38 Years |
Location | 15200 S.w Freeway, Sugar Land, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104958750 | NPI | - | NPPES |
0923286-01 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | K1598 (Texas) | Primary |
Entity Name | Arthritis & Lupus Clinic Of Houston Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154506269 PECOS PAC ID: 8022030063 Enrollment ID: O20090204000363 |
News Archive
Growing concerns about health has caused the scientific community to focus their interest on investigating functional foods which contribute to boosting the prevention and reduction of the risk of suffering from certain illnesses. The benefits of this product lies in its composition and, thus, its study, identification and subsequent extraction provides a useful tool which enables making high added-value products, given their high concentration of biologically active compounds.
A group of Chinese researchers recently conducted a phase 2 clinical trial to further evaluate the immunogenicity and safety of SARS-CoV-2 inactivated vaccine known as CoronaVac. The results are currently available on the medRxiv preprint server and demonstrate that the vaccine is well tolerated and without any notable dose-related safety concerns, which opens the door for phase 3 clinical trial.
The constant health education that dialysis patients receive can lead to boredom and noncompliance. But a Loyola University Medical Center study has found that brief, casual chats can be a significant benefit to patients.
Ipsen and the US company EpiVax, Inc. today announced that they have completed a collaborative project that provides a novel approach for creating next generation botulinum neurotoxin (BoNT) and Targeted Secretion Inhibitor (TSI) therapeutics.
A startling new preprint research paper posted to the medRxiv server warns against the use of commonly used non-steroidal anti-inflammatory drugs (NSAIDs) belonging to the category of cyclooxygenase inhibitors (COX inhibitors) in patients with coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Obianuju C Okeke, MD 15200 Southwest Fwy, 210, Sugar Land, TX 77478-3845 Ph: (281) 313-7000 | Obianuju C Okeke, MD 15200 S.w Freeway, 210, Sugar Land, TX 77478 Ph: (281) 313-7000 |
News Archive
Growing concerns about health has caused the scientific community to focus their interest on investigating functional foods which contribute to boosting the prevention and reduction of the risk of suffering from certain illnesses. The benefits of this product lies in its composition and, thus, its study, identification and subsequent extraction provides a useful tool which enables making high added-value products, given their high concentration of biologically active compounds.
A group of Chinese researchers recently conducted a phase 2 clinical trial to further evaluate the immunogenicity and safety of SARS-CoV-2 inactivated vaccine known as CoronaVac. The results are currently available on the medRxiv preprint server and demonstrate that the vaccine is well tolerated and without any notable dose-related safety concerns, which opens the door for phase 3 clinical trial.
The constant health education that dialysis patients receive can lead to boredom and noncompliance. But a Loyola University Medical Center study has found that brief, casual chats can be a significant benefit to patients.
Ipsen and the US company EpiVax, Inc. today announced that they have completed a collaborative project that provides a novel approach for creating next generation botulinum neurotoxin (BoNT) and Targeted Secretion Inhibitor (TSI) therapeutics.
A startling new preprint research paper posted to the medRxiv server warns against the use of commonly used non-steroidal anti-inflammatory drugs (NSAIDs) belonging to the category of cyclooxygenase inhibitors (COX inhibitors) in patients with coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
Vandana Khera, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 18717 University Blvd Bldg 2, Suite 105, Sugar Land, TX 77479 Phone: 281-208-3322 Fax: 281-208-3393 | |
Susan Vijayan Mathew, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 16811 Southwest Fwy Fl 3, Sugar Land, TX 77479 Phone: 281-275-0897 | |
Saif K Altaie, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 16655 Southwest Fwy, Sugar Land, TX 77479 Phone: 281-274-7000 | |
Priya N. Oolut, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 16659 Southwest Fwy Ste 421, Sugar Land, TX 77479 Phone: 281-325-0005 Fax: 713-512-2247 | |
Dr. Htut Kyaw Win, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy Ste 360, Sugar Land, TX 77479 Phone: 713-790-0841 Fax: 713-790-9963 | |
Cathlyn Anderson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 15200 S Us 59 Highway Suite 360, Sugar Land, TX 75075 Phone: 832-237-3500 Fax: 832-237-0200 | |
Angela Denise Mcgee, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11555 University Blvd, Sugar Land, TX 77478 Phone: 713-442-9100 |